vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and ORRSTOWN FINANCIAL SERVICES INC (ORRF). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $64.6M, roughly 1.1× ORRSTOWN FINANCIAL SERVICES INC). Over the past eight quarters, ORRSTOWN FINANCIAL SERVICES INC's revenue compounded faster (39.3% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Orrstown Financial Services Inc is a US regional bank holding company headquartered in Shippensburg, Pennsylvania. It offers a full range of retail and commercial banking solutions including deposit accounts, personal and business loans, mortgages, and wealth management services, primarily serving customers across central Pennsylvania and northern Maryland.

FLGT vs ORRF — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.1× larger
FLGT
$71.1M
$64.6M
ORRF
Faster 2-yr revenue CAGR
ORRF
ORRF
Annualised
ORRF
39.3%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FLGT
FLGT
ORRF
ORRF
Revenue
$71.1M
$64.6M
Net Profit
$21.8M
Gross Margin
30.2%
Operating Margin
21.1%
Net Margin
33.8%
Revenue YoY
-3.2%
Net Profit YoY
19.1%
EPS (diluted)
$0.04
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
ORRF
ORRF
Q1 26
$71.1M
$64.6M
Q4 25
$83.3M
$64.9M
Q3 25
$84.1M
$64.4M
Q2 25
$81.8M
$62.4M
Q1 25
$73.5M
$60.4M
Q4 24
$76.2M
$61.8M
Q3 24
$71.7M
$64.1M
Q2 24
$71.0M
$33.3M
Net Profit
FLGT
FLGT
ORRF
ORRF
Q1 26
$21.8M
Q4 25
$-23.4M
$21.5M
Q3 25
$-6.6M
$21.9M
Q2 25
$-19.0M
$19.4M
Q1 25
$-11.5M
$18.1M
Q4 24
$-5.9M
$13.7M
Q3 24
$-14.6M
$-7.9M
Q2 24
$-8.7M
$7.7M
Gross Margin
FLGT
FLGT
ORRF
ORRF
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
ORRF
ORRF
Q1 26
21.1%
Q4 25
-43.5%
42.3%
Q3 25
-18.3%
43.0%
Q2 25
-24.1%
39.6%
Q1 25
-26.9%
37.7%
Q4 24
-21.2%
27.7%
Q3 24
-23.8%
-15.4%
Q2 24
-26.6%
29.5%
Net Margin
FLGT
FLGT
ORRF
ORRF
Q1 26
33.8%
Q4 25
-28.1%
33.1%
Q3 25
-7.9%
34.0%
Q2 25
-23.2%
31.2%
Q1 25
-15.7%
29.9%
Q4 24
-7.7%
22.1%
Q3 24
-20.4%
-12.3%
Q2 24
-12.3%
23.3%
EPS (diluted)
FLGT
FLGT
ORRF
ORRF
Q1 26
$0.04
$1.12
Q4 25
$1.11
Q3 25
$1.13
Q2 25
$1.01
Q1 25
$0.93
Q4 24
$0.35
Q3 24
$-0.41
Q2 24
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
ORRF
ORRF
Cash + ST InvestmentsLiquidity on hand
$23.4M
$161.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$603.2M
Total Assets
$1.2B
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
ORRF
ORRF
Q1 26
$23.4M
$161.8M
Q4 25
$50.2M
Q3 25
$117.6M
Q2 25
$87.9M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$58.0M
Q2 24
$65.1M
Stockholders' Equity
FLGT
FLGT
ORRF
ORRF
Q1 26
$603.2M
Q4 25
$1.1B
$591.5M
Q3 25
$1.1B
$571.9M
Q2 25
$1.1B
$548.4M
Q1 25
$1.1B
$532.9M
Q4 24
$1.1B
$516.7M
Q3 24
$1.1B
$516.2M
Q2 24
$1.1B
$278.4M
Total Assets
FLGT
FLGT
ORRF
ORRF
Q1 26
$1.2B
$5.6B
Q4 25
$1.2B
$5.5B
Q3 25
$1.2B
$5.5B
Q2 25
$1.2B
$5.4B
Q1 25
$1.2B
$5.4B
Q4 24
$1.2B
$5.4B
Q3 24
$1.2B
$5.5B
Q2 24
$1.2B
$3.2B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

ORRF
ORRF

Net Interest Income$49.0M76%
Noninterest Income$15.6M24%

Related Comparisons